- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.12.25 | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.11.25 | Venus Concept targets sequential Q4 growth with Venus NOVA launch amid Venus Hair sale uncertainty | 2 | Seeking Alpha | ||
| 13.11.25 | Venus Concept Inc. Q3 Sales Decline | 3 | RTTNews | ||
| 13.11.25 | Venus Concept GAAP EPS of -$12.14, revenue of $13.78M | 3 | Seeking Alpha | ||
| 13.11.25 | Venus Concept Inc.: Venus Concept Announces Third Quarter 2025 Financial Results | 284 | GlobeNewswire (Europe) | TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen | |
| 13.11.25 | Venus Concept Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.11.25 | Venus Concept Inc. - 8-K, Current Report | - | SEC Filings | ||
| VENUS CONCEPT Aktie jetzt für 0€ handeln | |||||
| 10.11.25 | Venus Concept Inc.: Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments | 195 | GlobeNewswire (Europe) | TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company"), a global leader in medical aesthetic technology, announced today that it has received a 510(k) clearance... ► Artikel lesen | |
| 31.10.25 | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.10.25 | Venus Concept announces $11.48 million debt-to-equity exchange transaction | 1 | Seeking Alpha | ||
| 02.10.25 | Venus Concept Inc.: Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction | 141 | GlobeNewswire (Europe) | TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on September 30... ► Artikel lesen | |
| 02.10.25 | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.10.25 | Venus Concept Inc.: Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025 | 3 | GlobeNewswire (USA) | ||
| 22.09.25 | Venus Concept sichert sich Darlehen über 2 Mio. USD und genehmigt Boni für Führungskräfte | 1 | Investing.com Deutsch | ||
| 22.09.25 | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09.25 | Venus Concept Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.08.25 | Venus Concept Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.08.25 | Venus Concept outlines $20M hair business sale while targeting core aesthetics growth amid challenging environment | 2 | Seeking Alpha | ||
| 14.08.25 | Venus Concept Inc. - 10-Q, Quarterly Report | 1 | SEC Filings |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| ECKERT & ZIEGLER | 15,410 | -2,41 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| UNITEDHEALTH | 298,05 | +1,85 % | Aktien New York: Dow steuert mit Rekord auf 50.000 Punkte zu | NEW YORK (dpa-AFX) - Die Jahresauftakt-Rally an den US-Börsen ist am Dienstag weitergegangen. Der Leitindex Dow Jones Industrial stieg den zweiten Handelstag in Folge auf ein Rekordhoch und steuert... ► Artikel lesen | |
| THERMO FISHER | 520,10 | -1,55 % | Dividendenbekanntmachungen (15.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2969 EUR AMERICAN HOMES 4 RENT US02665T3068 0,3 USD 0,2555 EUR ARES CAPITAL... ► Artikel lesen | |
| TELADOC HEALTH | 6,496 | +0,15 % | BofA Securities lowers Teladoc stock price target to $7.50 on segment uncertainties | ||
| ROKU | 93,64 | -0,82 % | Evercore ISI upgrades Roku stock rating to Outperform on 2026 catalysts | ||
| BICO GROUP | 1,822 | -0,22 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,585 | -3,29 % | Plus Therapeutics Inc.: Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ for Leptomeningeal Metastases | HOUSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| RESMED | 215,00 | +1,18 % | Is This the Right Time to Add Resmed Stock to Your Portfolio? | ||
| ATOSSA THERAPEUTICS | 0,577 | +0,70 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer | SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet... ► Artikel lesen | |
| HENRY SCHEIN | 66,28 | -0,93 % | Henry Schein Allows KKR To Buy Up To 19.9% Of Stake, Lifts Annual Outlook; Stock Up Over 8% | MELVILLE (dpa-AFX) - Henry Schein, Inc. (HSIC), a distributor of health care products and services, said on Tuesday that its Board has approved an amendment to the strategic partnership agreement... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| LUMEXA IMAGING | 17,730 | +2,37 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| ALIGNMENT HEALTHCARE | 20,950 | +0,12 % | Where Alignment Healthcare Stands With Analysts |
VENUS CONCEPT INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,010 (+0,66 %) liegt der Kurs bei 1,530 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS CONCEPT INC finden Sie auf Wallstreet Online.